Trial · NCT04273802
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response rate (CR, CRi, PR) | 28 to 42 days after induction | Response to induction therapy |
| Secondary | Overall response rate (CR, CRi, PR, HI) | 28 to 42 days after induction | Response to induction therapy |
| Secondary | Event free survival | 42 months | Event free survival |
| Secondary | Response duration | 42 months | Duration of the response to induction therapy |
| Secondary | Overall survival | 42 months | Overall survival |
| Secondary | Toxicity profile - Duration of cytopenias | 42 months | Duration of cytopenias |
| Secondary | Toxicity profile - life threatening or fatal cytopenias | 42 months | Number of life threatening or fatal cytopenias |
| Secondary | Toxicity profile - hospitalization | 42 months | Time spent in hospital for induction and consolidation cycles |
| Secondary | Evaluation of minimal residual disease (MRD) after induction and after the last consolidation | 42 months | Evaluation of MRD by flow cytometry |
| Secondary | Evaluation of minimal residual disease (MRD) after induction and after the last consolidation | 42 months | Evaluation of variant allelic frequency (VAF) of Baseline mutations |
| Secondary | Soluble Fms-like tyrosine kinase 3 ligand concentration (sFLc) in plasma during induction | 42 months | sFLc plasma level assessments at day 1 of induction just before starting treatment, and then at days 8, 15 and 22 of induction |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04273802/registered